april
novel
swinelineag
influenza
infect
report
world
health
organis
center
diseas
control
prevent
cdc
atlanta
viru
detect
two
children
adjac
counti
southern
california
present
febril
respiratori
ill
case
epidemiolog
link
neither
child
exposur
swine
subsequ
phylogenet
characteris
us
index
case
show
viru
uniqu
genom
composit
previous
identifi
six
gene
pa
ha
np
ns
similar
virus
previous
identifi
triplereassort
swine
influenza
virus
north
american
pig
remain
two
gene
na
deriv
eurasian
swine
influenza
virus
particular
gene
constel
never
previous
identifi
human
reservoir
follow
origin
identif
influenza
unit
state
sustain
humantohuman
transmiss
seen
countri
june
declar
viru
respons
first
influenza
pandem
centuri
first
case
scotland
detect
end
april
coupl
return
honeymoon
mexico
initi
public
health
respons
outbreak
contain
exercis
aim
prevent
spread
infect
detect
case
take
action
prevent
case
infect
other
exercis
initi
base
clinic
epidemiolog
criteria
tabl
patient
met
criteria
immedi
given
treatment
isol
rapid
real
time
revers
transcriptas
polymeras
chain
reaction
rtrtpcr
initi
contact
trace
undertaken
order
treat
contact
confirm
case
soon
first
detect
person
person
transmiss
confirm
occur
scotland
consequ
epidemiolog
criteria
longer
use
contain
exercis
base
clinic
criteria
test
continu
carri
period
outbreak
period
apriljuli
west
scotland
specialist
virolog
centr
wossvc
test
clinic
sampl
figur
posit
overal
period
apriljuli
rang
per
month
consequ
clinic
diagnosi
found
wrong
major
case
larg
number
viral
infect
drug
diseas
caus
diseas
present
similar
present
tabl
especi
true
respiratori
pathogen
present
studi
sought
determin
respiratori
pathogen
diagnos
case
contain
phase
apriljuli
respiratori
sampl
submit
patient
clinic
diagnosi
state
specimen
request
form
initi
test
use
univers
influenza
real
time
rtrtpcr
assay
specif
real
time
rtrtpcr
assay
sampl
neg
test
hospitalis
patient
patient
deem
risk
sever
respiratori
infect
eg
immunocompromis
pregnant
patient
patient
attend
gp
servic
take
part
local
nation
surveil
scheme
full
respiratori
screen
carri
see
detail
regard
full
respiratori
screen
note
inform
deriv
sampl
request
form
regard
sampl
gp
servic
take
part
surveil
scheme
mention
ii
followup
sampl
known
posit
patient
iii
sampl
patient
clinicalset
detail
initi
screen
test
conduct
determin
respiratori
pathogen
misdiagnos
examin
result
sampl
given
full
respiratori
screen
period
apriljuli
clinic
diagnos
found
neg
sampl
submit
includ
gargl
throat
swab
nasal
swab
nasopharyng
aspir
sputum
endotrach
secret
number
collect
month
age
patient
shown
tabl
binomi
confid
interv
shown
age
group
total
nucleic
acid
extract
respiratori
specimen
use
qiaamp
viral
rna
kit
qiagen
crawley
unit
kingdom
accord
manufactur
instruct
realtim
rtpcr
carri
order
detect
influenza
gener
assay
specif
assay
b
c
rsv
rhinoviru
parainfluenza
human
metapneumoviru
coronaviru
adenoviru
mycoplasma
pneumonia
oligonucleotid
primer
probe
tibmolbiol
berlin
germani
outlin
tabl
primer
probe
influenza
gener
assay
specif
assay
describ
elsewher
assay
develop
wossvc
use
frontlin
test
respiratori
sampl
sinc
assay
shown
sensit
specif
inhous
develop
procedur
via
particip
numer
extern
qualiti
assess
scheme
eqa
includ
provid
health
protect
agenc
hpa
qualiti
control
molecular
diagnost
qcmd
assay
use
primer
final
concentr
probe
reaction
volum
onestep
rtrtpcr
perform
rna
extract
platinum
onestep
qrtpcr
kit
invitrogen
life
technolog
paisley
uk
abi
prism
sd
realtim
platform
appli
biosystem
follow
thermal
profil
use
singl
cycl
revers
transcript
min
min
revers
transcriptas
inactiv
dna
polymeras
activ
follow
amplif
cycl
sec
sec
annealingextens
step
data
acquisit
occur
anneal
step
cycl
threshold
cycl
ct
sampl
calcul
determin
point
fluoresc
exceed
threshold
limit
percentag
detect
rate
pathogen
analys
monthli
overal
studi
period
binomi
confid
interv
also
determin
detect
rate
chisquar
test
use
comparison
two
data
set
pleas
note
ethic
approv
requir
paper
sampl
collect
part
routin
diagnost
work
examin
detect
rate
fourmonth
period
show
respiratori
pathogen
detect
sampl
submit
confid
interv
tabl
numer
pathogen
detect
sampl
commonli
detect
pathogen
rhinoviru
detect
sampl
test
confid
interv
similarli
detect
month
examin
adenoviru
also
commonli
detect
confid
interv
parainfluenza
show
typic
activ
detect
sampl
collect
april
confid
interv
decreas
activ
thereaft
juli
confid
interv
p
interestingli
parainfluenza
pathogen
normal
associ
winter
activ
present
unexpectedli
larg
number
sampl
period
sampl
overal
confid
interv
mirror
increas
activ
april
confid
interv
juli
confid
interv
p
detect
rate
remain
pathogen
low
show
particular
pattern
month
examin
studi
highlight
problem
use
clinic
algorithm
detect
period
low
incid
found
clinician
frequent
misdiagnos
common
respiratori
pathogen
springsumm
outbreak
scotland
find
similar
result
found
recent
audit
patient
hospitalis
clinic
diagnos
infecti
diseas
unit
scotland
pathogen
misdiagnos
part
virus
expect
encount
springsumm
month
although
pathogen
includ
respiratori
screen
detect
least
one
occas
rhinoviru
commonli
detect
pathogen
surpris
find
sinc
rhinoviru
detect
year
round
moreov
recognis
common
caus
common
cold
increasingli
implic
sever
clinic
syndrom
adenoviru
human
metapneumoviru
also
frequent
detect
unexpect
find
frequent
detect
parainfluenza
pathogen
tradit
recognis
winter
pathogen
howev
data
show
numer
case
parainfluenza
apriljuli
mirror
activ
unexpect
summer
activ
parainfluenza
mirror
parainfluenza
also
unexpectedli
detect
summer
month
data
shown
suggest
epidemiolog
establish
virus
parainfluenza
reexamin
light
new
sensit
molecular
assay
note
major
sampl
submit
laboratori
found
neg
real
time
rtrtpcr
particip
variou
eqa
scheme
assay
use
laboratori
shown
highli
sensit
consequ
larg
number
neg
result
unlik
caus
pathogen
alreadi
test
screen
howev
respiratori
screen
includ
intern
control
consequ
fals
neg
due
inhibit
may
occur
nevertheless
number
sampl
affect
like
small
sinc
recent
inhous
audit
found
inhibit
occur
throat
nasal
swab
submit
laboratori
poor
sampl
may
also
led
fals
neg
result
howev
case
inhibit
contribut
factor
like
minim
rule
possibl
sampl
may
contain
respiratori
pathogen
current
includ
respiratori
screen
eg
boca
bacteri
respiratori
pathogen
futur
use
larger
test
panel
either
develop
exist
servic
use
altern
method
eg
microarray
would
use
examin
neg
sampl
anoth
possibl
infect
noninfect
agent
could
present
exampl
previouslyment
audit
patient
present
infecti
diseas
unit
found
altern
nonrespiratori
diagnosi
patient
initi
clinic
diagnos
anoth
explan
could
number
sampl
actual
worri
well
asymptomat
contact
known
suspect
case
audit
similar
one
outlin
public
would
help
clarifi
issu
note
sampl
examin
repres
code
protocol
may
repres
popul
larg
consequ
certain
patient
group
either
risk
sever
infect
may
overrepres
final
data
whether
case
present
studi
show
numer
respiratori
pathogen
misdiagnos
misdiagnosi
would
mani
undesir
consequ
exampl
potenti
seriou
condit
may
wrongli
diagnos
addit
larg
number
individu
like
unnecessarili
treat
oseltamivir
involv
unnecessari
cost
would
also
expos
individu
side
effect
oseltamivir
note
could
well
emot
cost
wrongli
label
swine
flu
especi
earli
stage
pandem
sever
outcom
ill
still
larg
unknown
hospitalis
patient
unnecessari
infect
control
procedur
may
implement
diseas
surveil
may
also
inaccur
affect
public
health
measur
lead
increas
panicconcern
gener
public
one
way
overcom
issu
would
incorpor
nearpati
test
compon
algorithm
outlin
would
doubt
reduc
amount
unnecessari
treatment
isol
would
ensur
surveil
data
accur
test
would
need
rapid
sensit
specif
although
number
method
describ
expens
comparison
pcrbase
method
insensit
nonspecif
result
pcr
method
may
requir
investig
influenza
neg
sampl
low
preval
period
time
period
examin
studi
pcr
may
also
requir
confirm
posit
result
author
declar
compet
interest
wfc
conceiv
studi
rg
examin
data
wrote
manuscript
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
